South Africa, July 24 -- The African Development Bank Group has finalised a loan of up to $15 million to the Biologicals and Vaccines Institute of South Africa Ltd (Biovac) to support a new multi-vaccine manufacturing facility in Cape Town that will significantly expand Africa's domestic capacity to produce vaccines.The financing forms part of an expansion programme that will raise Biovac's total annual manufacturing capacity up to 500 million doses. Once complete, Biovac is expected to become Africa's first end-to-end producer of oral cholera vaccine and South Africa's first locally produced inactivated polio vaccine, and the first on the continent to produce inactivated polio vaccine through technology-transfer partnerships with Sanofi, t...